Form 4: Esperion Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
J Martin Carroll, a Director of Esperion Therapeutics, Inc., reported multiple transactions in common stock on July 13, 2026.
Summary
- Disposition to the issuer: disposed of 177,523 Common Stock on July 13, 2026 (Direct).
- Disposition to the issuer: disposed of 21,000 Stock Option (right to buy) on July 13, 2026 (Direct).
- Disposition to the issuer: disposed of 32,500 Stock Option (right to buy) on July 13, 2026 (Direct).
- Disposition to the issuer: disposed of 44,000 Stock Option (right to buy) on July 13, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
J Martin Carroll — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-13 | Disposition to the issuer | Common Stock | 177,523 | — | — | 0 |
| 2026-07-13 | Disposition to the issuer | Stock Option (right to buy) | 21,000 | — | — | 0 |
| 2026-07-13 | Disposition to the issuer | Stock Option (right to buy) | 32,500 | — | — | 0 |
| 2026-07-13 | Disposition to the issuer | Stock Option (right to buy) | 44,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-13 | Disposition to the issuer (177,523 shares) |
| 2026-07-13 | Disposition to the issuer (21,000 shares) |
| 2026-07-13 | Disposition to the issuer (32,500 shares) |
| 2026-07-13 | Disposition to the issuer (44,000 shares) |
Keywords
insider transaction, Form 4, ESPR, Esperion Therapeutics, Inc., neutral, J Martin Carroll
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.